DJIA 16,514.37 65.12 0.40%
NASDAQ 4,161.46 0.00 0.00%
S&P 500 1,879.55 7.66 0.41%
market minute promo

Novavax, Inc.

NASDAQ: NVAX

4.31 0.14 (3.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVAX $4.31 3.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.22
Previous Close $4.17
Daily Range $4.20 - $4.36
52-Week Range $1.68 - $6.95
Market Cap $901.0M
P/E Ratio -13.45
Dividend (Yield) $0.00 (0.0%)
Volume 3,218,269
Average Daily Volume 5,212,750
Current FY EPS -$0.27

Sector

Healthcare

Industry

Drugs

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary Rss Feed

Are Inovio and Rockwell Medical In for a Bad Year?

These biopharmas have started the year poorly and could be in for a bad 2014.

Stock To Watch: Novavax (NVAX) In Perilous Reversal

Novavax: Promising Pipeline And Stable Revenue Add To Upside

Today's Dead Cat Bounce Stock: Novavax (NVAX)

Insiders And Analysts Like These Speculative Small Cap Stocks

5 Stocks With Big Insider Buying

Insider Trading Alert - UNP, OPK And NVAX Traded By Insiders

Novavax Is Now Oversold (NVAX)

Benzinga's Top #PreMarket Gainers

Novavax's CEO Discusses Q4 2013 Results - Earnings Call Transcript

After-Hours Earnings Report for March 10, 2014 : URBN, UNFI, CASY, NVAX, SMLP, PWRD, FCEL, EXK, POW

After-Hours Earnings Report for March 10, 2014 : URBN, UNFI, CASY, NVAX, SMLP, PWRD, FCEL, EXK, POWR, CISG, MED, PLOW

See More NVAX News...

NVAX's Top Competitors

NVAX $4.31 (3.36%)
Current stock: NVAX
AMGN $119.30 (1.95%)
Current stock: AMGN
GILD $72.86 (1.76%)
Current stock: GILD
BIIB $306.20 (2.76%)
Current stock: BIIB